Two years’ experience with denosumab for children with Osteogenesis imperfecta type VI

Title
Two years’ experience with denosumab for children with Osteogenesis imperfecta type VI
Authors
Keywords
Osteogenesis imperfecta VI, SERPINF1, RANKL Antibody, Denosumab, Bone mineral density
Journal
Orphanet Journal of Rare Diseases
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-09-25
DOI
10.1186/s13023-014-0145-1

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now